Paragon Care Ltd (ASX: PGC) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Paragon Care Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $215.83 million
P/E Ratio 14.71
Dividend Yield 4.57%
Shares Outstanding 644.27 million
Earnings per share 0.024
Dividend per share 0.02
Year To Date Return -1.11%
Earnings Yield 6.80%
Franking 100%
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Paragon Care Ltd (ASX: PGC)
Latest News

Lab worker puts hands in the air and dances around
Earnings Results

Paragon Care (ASX: PGC) share price soars 5% on $8.3 million profit

Financial year 2021 saw Paragon back in the green...

Read more »

ASX shares Victorian state 2021 Budget written on chalkboard with colourful balloons
Share Market News

ASX winners and losers from the Victorian budget

The Victorian state government handed down its budget today with billions in new taxes and cuts that will create winners…

Read more »

Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares
Share Market News

Here’s why the Paragon (ASX:PGC) share price has surged 19% today

The Paragon Care Ltd (ASX: PGC) share price is soaring today following updates of the company's debt financing and third…

Read more »

asx share price growth represented by rocket flying up increasing bar chart.
Healthcare Shares

Why the Paragon Care share price is rocketing 83% today

The Paragon Care Ltd (ASX: PGC) share price is a standout performer on the market today as investors react to…

Read more »

beat the share market
Share Market News

Why these 3 ASX shares surged higher today

While the S&P/ASX 200 Index (INDEXASX: XJO) ended the day slightly down, here are 3 ASX shares that have shown…

Read more »

Large man falling off end of plank
Share Fallers

Why ARB, OneVue, Origin Energy, & Paragon Care are tumbling lower

The ARB Corporation Limited (ASX:ARB) share price and the Origin Energy Ltd (ASX:ORG) share price are two of four tumbling…

Read more »

Skydive Upside Down
Share Market News

Why the Paragon share price has plummeted 19% today

The Paragon Care Ltd (ASX: PGC) share price has plummeted by 19% in morning trade after the release of the…

Read more »

Defensive Shares

3 healthcare ASX shares I’d buy for my portfolio

Here are 3 healthcare ASX shares I would buy for my portfolio.

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
21 Mar 2022 $0.0060 100.00% Interim 26 Apr 2022
13 Sep 2021 $0.0100 100.00% Final 01 Oct 2021
21 Mar 2019 $0.0110 100.00% Interim 26 Apr 2019
14 Sep 2018 $0.0200 100.00% Final 12 Oct 2018
15 Mar 2018 $0.0110 100.00% Interim 12 Apr 2018
07 Sep 2017 $0.0190 100.00% Final 06 Oct 2017
09 Mar 2017 $0.0110 100.00% Interim 06 Apr 2017
15 Sep 2016 $0.0140 100.00% Final 06 Oct 2016
09 Mar 2016 $0.0080 100.00% Interim 06 Apr 2016
27 Aug 2015 $0.0080 100.00% 18 Sep 2015
05 Mar 2015 $0.0060 100.00% 31 Mar 2015
08 Oct 2014 $0.0075 100.00% Final 31 Oct 2014
07 Mar 2014 $0.0050 100.00% Interim 31 Mar 2014
04 Oct 2013 $0.0100 100.00% Final 31 Oct 2013

PGC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Paragon Care Ltd

Paragon Care Ltd is a medical device company. It is a provider of medical equipment, devices and consumables to the healthcare market. The company provides solutions to various healthcare markets that is Aged care; Hospital and Acute care;Primary Care; Eye Care; Storage Solutions; and E-Health.

PGC Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 May 2022 $0.35 $-0.02 -5.41% 649,787 $0.37 $0.37 $0.35
13 May 2022 $0.37 $0.03 8.82% 517,089 $0.34 $0.37 $0.34
12 May 2022 $0.34 $-0.01 -2.86% 164,779 $0.34 $0.35 $0.34
11 May 2022 $0.35 $0.00 0.00% 28,097 $0.34 $0.35 $0.34
10 May 2022 $0.35 $-0.01 -2.78% 445,059 $0.35 $0.37 $0.34
09 May 2022 $0.36 $-0.02 -5.26% 242,102 $0.37 $0.37 $0.36
06 May 2022 $0.38 $0.00 0.00% 86,759 $0.37 $0.38 $0.35
05 May 2022 $0.38 $0.00 0.00% 23,355 $0.38 $0.38 $0.38
04 May 2022 $0.38 $0.00 0.00% 136,087 $0.39 $0.39 $0.38
03 May 2022 $0.39 $0.01 2.63% 80,585 $0.40 $0.40 $0.38
02 May 2022 $0.38 $-0.04 -9.64% 360,175 $0.42 $0.42 $0.36
29 Apr 2022 $0.42 $0.04 10.53% 323,909 $0.39 $0.42 $0.38
28 Apr 2022 $0.38 $0.02 5.48% 276,488 $0.37 $0.38 $0.36
27 Apr 2022 $0.37 $0.00 0.00% 504,745 $0.36 $0.37 $0.36
26 Apr 2022 $0.37 $-0.02 -5.19% 255,947 $0.38 $0.38 $0.36
22 Apr 2022 $0.39 $0.02 5.41% 132,765 $0.38 $0.39 $0.38
21 Apr 2022 $0.37 $0.01 2.78% 235,308 $0.37 $0.37 $0.35
20 Apr 2022 $0.36 $-0.01 -2.74% 230,580 $0.37 $0.37 $0.36

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
26 Apr 2022 Shane Tanner Buy 19 $7,200
Dividend Reinvestment Plan (DRP).
26 Apr 2022 Mark Simari Buy 6 $2,442
Dividend Reinvestment Plan (DRP).
26 Apr 2022 Brent Stewart Buy 55 $20,257
Dividend Reinvestment Plan (DRP).
20 Apr 2022 Geoffrey Sam Buy 32 $12,008
On-market trade.
04 Mar 2022 Shane Tanner Buy 160 $62,548
On-market trade.
01 Mar 2022 Geoffrey Sam Buy 195 $74,386
On-market trade.
01 Oct 2021 Shane Tanner Buy 40 $10,000
Dividend Reinvestment Plan (DRP).
01 Oct 2021 Mark Simari Buy 15 $3,914
Dividend Reinvestment Plan (DRP). As per announcement on 01/10/2021
01 Oct 2021 Brent Stewart Buy 129 $32,463
Dividend Reinvestment Plan (DRP).
01 Oct 2021 Geoffrey Sam Buy 7 $1,993
Dividend Reinvestment Plan (DRP).

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Shane Francis Tanner Non-Executive DirectorNon-Executive Chairman Dec 2005
Mr Tanner was one of the Co-Founders of Paragon Care Limited and has experience at both senior executive and board level, bringing more than 25 years experience in healthcare and strategy. Shane has orchestrated and been responsible for numerous small and large-scale acquisitions. He has also helped to establish and guide a number of businesses. Shane is currently Chairman of Guardian Alphabet Holdco Pty Ltd. Previously, Shane was CEO of Symbion Health, one of Australia's largest diagnostic businesses and Chairman of Vision Eye Institute. Cronos Australia Limited (CAU) Vision Eye Institute, Funtastic Limited, Rhythm Biosciences Limited He is a Member of Investment Review Committee.
Mr Philip (Phil) Nicholl Executive Director Nov 2019
Mr Nicholl is currently the CEO of one of Paragon's businesses, a company in the orthopaedics market in Australia and New Zealand. Mr Nicholl has experience in the medical devices industry having occupied senior executive roles for the companies including Stryker and Cochlear.
Mr Mark Anthony Simari Non-Executive Director Apr 2007
Mr Simari is an experienced professional in the health industry and has over 12 years Board experience in a range of organisations, including not for profits. Mark was the former Chief Executive Officer and Managing Director and Co- Founder of Paragon Care during his tenure (between 2008 and 2018). He was instrumental in Paragon Care becoming one of the largest independent healthcare suppliers in the Australian and New Zealand market, creating a healthcare platform spanning across capital equipment, consumables, devices and service and maintenance. Mark has also held various directorship positions in other companies such as Tali Digital Limited, Social Investment Australia Limited, Sage Capital Group Pty Ltd, InterPrac Financial Planning Pty Ltd and DKN Financial Group. Mark is presently the Chairman of Unisono Pty Limited and Akita Consulting. He also holds advisory roles with Fruitlink Pty Ltd. He is Chair of Risk Committee, Member of Investment Committee.
Mr Mark Robert Hooper Chief Executive OfficerManaging Director Apr 2022
Mr Hooper has career in healthcare sector in the Australian market. Mr Hooper was appointed Managing Director & CEO of Sigma in August 2010 and over the past decade he has led the Sigma business through a divestment of the Pharmaceutical division and several acquisitions, as well as an internal transformation project to generate operating efficiencies and the renewal of Sigma's national distribution centre network. He was also Chair of the Wholesaler industry body (NPSA) from October 2015 to August 2020. Prior to joining Sigma, Mr Hooper had a range of experience in finance, commercial and operational roles, primarily in the mining and pharmaceutical industries. Mr Hooper is a former Chief Financial Officer and Executive Director of PaperlinX Limited. From 2006 to 2008, Mr Hooper was the Chief Financial Officer and Chief Operating Officer for the Pharmacy and Consumer business for Symbion Health Limited. Prior to that he was the Chief Financial Officer of Sigma from 2001 to 2006.
Mr John Walstab Executive Director Feb 2022
Mr Walstab was the Group Managing Director and CEO of Quantum Health Group and he has nearly 40 years' experience in medical equipment distribution across Australia and Asia. Mr Walstab was the founder of InSight Oceania (Quantum Healthcare) and he joined the Board of Quantum Health Group in 2003. Prior to that, Mr Walstab was the Managing Director of ATL Australia (Philips Medical Systems ANZ).
Mr Geoffrey Joseph Sam Non-Executive Director Jun 2016
Mr Sam has held numerous ASX listed board positions including Chairman of Money 3, Director of Hutchison's Childcare Services and Managing Director of Nova Health. Prior to his appointments to ASX listed companies, Geoffrey undertook numerous Chief Executive positions at Adelaide based hospitals. He is currently the Co-Founder and Director of HealtheCare Australia Pty Ltd, a privately owned health care company comprising a portfolio of 35 hospitals and a community nursing and rehabilitation business. He is the Chairman of Investment Review Committee and Member of Risk Committee
Mr Alan Timothy McCarthy Non-Executive Director Feb 2022
Mr McCarthy was a Non-Executive Director of Quantum Health Group and he has over 30 years' experience spanning public health and private health services across the Asia Pacific region. Mr McCarthy's prior roles include the CEO at Alpenglow Australia and New Zealand, Managing Director of Philips (ANZ), Vice-President at CareFusion, Country Manager ANZ at Cardinal Health and General Manager of Diagnostic Imaging at Mayne Health/Health Care of Australia. Mr McCarthy is currently a Non-Executive Director of Q Scan and RHC Group Ltd and the CEO of AdvaHealth Solutions.
Mr Brent Stewart Non-Executive Director May 2018
Mr Stewart is an experienced company executive and director having occupied numerous senior executive and board roles over the past 25 years. He established and grew a company in Australia and New Zealand (Market Equity Pty Ltd) before selling to a large multinational group (Aegis PLC). Brent has a long association with various segments of the healthcare sector in Australia and internationally. Currently, Brent occupies Non-Executive roles at HBF Health Ltd, Etherington Inc and Argonaut Ltd. He is a Member of the Risk Committee.
Ms Melanie Jaye Leydin Company Secretary Jun 2018
Stephen Munday Chief Financial Officer
Melanie Jaye Leydin Company Secretary

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Perpetual Corporate Trust Ltd 50,418,386 14.92%
First Samuel Ltd Acn 086243567 <Anf Its Mda Clients A/C> 24,885,164 7.36%
Berne No 132 Nominees Pty Ltd <737539 A/C> 16,717,541 4.95%
Citicorp Nominees Pty Limited 16,329,042 4.83%
Buttonwood Nominees Pty Ltd 5,678,195 1.68%
Jmt Investment Group Vic Pty Ltd <John Turner Super Fund A/C> 5,000,000 1.48%
Negroni Holdings Pty Ltd <The Dfn A/C> 4,727,531 1.40%
Mr Paul Andrew Schollum & Mrs Katrina Maree Caldwell & Mrs Deborah Anne Moss 4,717,320 1.40%
Shemozel Pty Ltd <Shemozel A/C> 4,561,256 1.35%
HSBC Custody Nominees (Australia) Limited 4,506,273 1.33%
Jmt Investment Group Vic Pty Ltd 4,240,000 1.25%
Newmeld Pty Ltd <Newmeld Super Fund A/C> 4,078,172 1.21%
Heath Nominees (Aust) Pty Ltd <The Heath Family A/C> 3,782,924 1.12%
Grills Investments Pty Ltd <Grills Discretionary Trust> 3,773,585 1.12%
Mrs Michelle Stewart & Mr Brent Michael Stewart <Brent Stewart Super A/C> 3,246,334 0.96%
Mr Paul Andrew Schollum & Mrs Katrina Maree Caldwell & Mrs Deborah Anne Moss (I) 3,106,538 0.92%
Lora Falls Pty Ltd <The Fehrmann Family Trust> 3,000,000 0.89%
Heath Super (Aust) Pty Ltd <Heath Super Fund A/C> 2,870,092 0.85%
John Keith Radley & Paul Andrew Schollum <Paul Schollum Family> 2,595,540 0.77%
Grayson Nominees Pty Ltd <Grayson Investment A/C> 2,500,000 0.74%